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ABSTRACT
Diabetes mellitus is a disease that affects about 387 million people throughout the
world. It is characterized by the body’s inability to secrete or respond to insulin properly.
As a result, diabetes mellitus is associated with hyperglycemia, the cause of many severe
complications. Calcification in blood vessel walls, one of the most adverse complications
of diabetes, may trigger heart failure, hypertension, plaque rupture, stroke, and coronary
ischemia. In vitro and in vivo studies suggest that vascular calcification is a regulated
process involving inhibitors and activators and resembling osteogenesis in bone. High
glucose levels have been shown to induce endothelial cell dysfunction, expression of
calcification biomarkers in vascular smooth muscle cells, and activation of fibroblasts.
The purpose of this study is to investigate the interactions between co-cultured vascular
endothelial cells, smooth muscle cells, and fibroblasts under diabetic/hyperglycemic and
normal conditions.
Human coronary artery smooth muscle cells, human aortic adventitial fibroblasts,
and human aortic endothelial cells were co-cultured in pairs with alternation of one cell
type on the membrane of the Transwell insert and the other on the bottom of the well.
The cells were cultured under high glucose levels or normal conditions for 2 weeks. We
performed immunofluorescence staining to examine the production of caspase-3 for
apoptosis as well as osteocalcin and alkaline phosphatase as markers of calcification.
Each surface was also stained with Alizarin Red Solution to observe the accumulation of
calcium.
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The immunofluorescent alkaline phosphatase and Alizarin Red S stains indicated
that all of the co-cultures, regardless of diabetic or nondiabetic conditions, induced
expression of alkaline phosphatase and calcium. Osteocalcin was only seen on the cell
surface of smooth muscle cells cultured on the membrane with fibroblasts in diabetic
conditions and fibroblasts cultured on the membrane with smooth muscle cells in diabetic
conditions.
This study shows that intercellular communications between smooth muscle cells
and fibroblasts could contribute to calcification of the vascular wall under diabetic
conditions.
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CHAPTER ONE
INTRODUCTION & BACKGROUND
1.1.

Diabetes Mellitus
Diabetes mellitus, commonly known as diabetes, is characterized by the body’s

inability to secrete or respond to insulin properly. Insulin is a hormone that is important
in the regulation of blood glucose levels. As a result of this defect, diabetes mellitus is
associated with hyperglycemia (a pathologically elevated blood glucose level) which is
attributed to the cause of many secondary complications and failure of various organs
such as the kidneys, eyes, heart, nerves, and blood vessels [1]. Diabetes mellitus is
considered equivalent to cardiovascular disease due to the high rate of complications
experienced by the patients with this ailment [3]. About 387 million people throughout
the world are affected by diabetes [2]. The development of diabetes mellitus is related to
several pathogenic process such as insulin deficiency due to the autoimmune destruction
of β-cells in the pancreas, which produce insulin within the islets of Langerhans, and
abnormalities in the receptor tissues resulting in resistance to insulin. Defects in the
insulin pathway action and impairment of the secretion of insulin are commonly both
found in the same patient, so it is often hard to decipher the primary cause of
hyperglycemia [1]. Although this common disease causes many complications and
multiple studies have been conducted in order to characterize diabetes, further
investigation is still needed due to the plethora of factors that play a role in the onset of
diabetes. It is a result of many various factors such as genetics, autoimmune dysfunction,
lifestyle, and environment [4]. Diabetes mellitus and its complications are not only a
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burden to individuals suffering from the disease, but also the global economy as a whole,
accounting for $245 billion in medical costs and lost work and wages within the United
States in 2012 alone [5]. As much as 10 percent of many countries’ healthcare budgets is
spent on treatment of diabetes [2].
Most diabetic patients fall into two etiopathogenetic categories. Type 1 diabetes is
caused by deficiency of insulin secretion. Type 2 diabetes is considerably more common,
accounting for about 90-95% of the cases and is caused by a combination of insulin
deficiency and insulin resistance of the body cells [1]. Type 1 diabetes is triggered by the
autoimmune system attacking the β-cells within the pancreatic islets. β-cells secrete
insulin in order to lower blood glucose levels. Insulin is a hormone that plays a major role
in glucose homeostasis; it stimulates glucose uptake into fat and muscle and suppresses
the output of glucose from the liver. Without the native islet cells to produce insulin in
the body, patients must use outside sources to make up for the lack of this important
hormone in their bodies.

Type 1 diabetes is treated through insulin injections to

compensate for the lack of β-cells. This less prevalent form of diabetes is typically
diagnosed in childhood or young adulthood and must be controlled through constant
monitoring and treatment throughout the person’s life [2].
The development of type 2 diabetes is contributed to multiple mechanisms. It is
characterized by insufficient insulin secretion from the β-cells, as well as insulin
resistance of target tissues. Hyperglycemia occurs when the secretion of insulin is not
enough to compensate for insulin resistance. Obesity causes further insulin resistance,
which is why risk in type 2 diabetic patients is enhanced by obesity and dietary control is
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crucial in the treatment of type 2 diabetes [2]. Insufficient insulin secretion could be due
to a decrease in the quantity of β-cells, the rate that the individual cells secrete insulin, or
both. Recent evidence suggests that alterations in the β-cell identity may also contribute
to defective insulin secretion through changes in the β-cell transcription factors [2].
Patients diagnosed with type 2 diabetes are reported to have a 2-fold to 4-fold higher risk
of cardiovascular mortality rate compared to individuals without diabetes [3].

1.2.

Vascular Calcification
Calcification of vessels refers to hydroxyapatite deposits building up within

cardiovascular tissues. Researchers and scientists have recognized calcification for more
than 200 years, but the pathogenesis still has yet to be understood [6]. Calcification may
cause many negative clinical consequences, some of these including heart failure,
hypertension, plaque rupture, stroke, and coronary ischemia [7].

The presence of

calcified plaque in coronary arteries predicts an increase in mortality by 1.7-fold. When
this calcification is extensive, there is a 60-fold predicted increase in mortality.
Calcification is observed in almost all patients diagnosed with cardiovascular disease [7].
Type 2 diabetic patients are more likely to develop macrovascular calcification than
nondiabetic patients. This may be attributed to elevated pulse pressure in elastic arteries
of the legs, stiffening of arterial tone, and an accelerated occlusive atherosclerosis process
[6].
In vitro and in vivo studies suggest that vascular calcification is a regulated
process involving inhibitors and activators and resembling osteogenesis in bone [6].
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Calcium deposits within vasculature can be similar to bone from a macroscale level to
nanoscale level [7].

Cellular components of deposits may include osteoclasts,

osteoblasts, chondroclasts, chondroblasts, pericytes, osteocytes, vascular cells, and
lymphocytes [7].

Analyzation of vascular lesion mineral content and cell cultures

through energy dispersive x-rays consistently yields calcium phosphate molar ratios
matching hydroxyapatite mineral [7]. Spectroscopy using nuclear magnetic resonance of
calcified plaques reveals surface features matching bone on a molecular level [7]. In
vitro, high glucose levels have been shown to induce expression of osteopontin and
induce cell proliferation in vascular smooth muscle cells as well as transforming them
into osteoblast-like cells [6].
In addition to transdifferentiation of vascular cells, calcification can also cause
stiffening of a vessel [6]. Calcium deposits in a vessel can create a compliance mismatch
between the rigid plaques and more compliant artery well tissues and, consequently,
affect plaque stability. Under the mechanical stress an artery is subjected to, this can
increase the risk of mechanical failure at the interface, resulting in plaque rupture. Plaque
rupture is the thought to be the cause of most stroke and myocardial infarction events [7].
Calcium deposits cause a dramatic redistribution of stress in plaque-reducing the stress in
some regions while increasing it in others [7].
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1.2.1. Medial Calcification vs. Intimal Calcification
The two categories of vascular calcification according to location are medical
calcification and intimal calcification. Intimal calcification appears as aggregates of
calcium deposits on the tunica intima. The calcification then extends into the tunica
media from the tunica intima [6]. It takes the form of atherosclerotic vascular disease and
involves vascular smooth muscle cells and inflammatory macrophages in regions of the
atherosclerotic plaque that are lipid-rich [8]. Intimal calcification is associated with
ischemic heart disease due to embolism formation or obstruction of the vessel through
calcified plaque build-up [8].
Medial calcification, also known as Mönkeberg’s arteriosclerosis, often
affects the tunica media in patients with diabetes mellitus [9]. It is not associated with
obstruction of the vessel lumen, as it does not involve the tunica intima, but it does
decrease the compliance and elasticity [8]. This can lead to formation of atherosclerosis,
reduction in perfusion [9], left ventricular hypertrophy, and systolic hypertension [8].
Medial artery calcification is a result of elevated levels of serum phosphate and calcium
and is prognostic for diabetic complications, including mortality and amputation, in
patients diagnosed with type 2 diabetes [9]. Both types of calcification often occur in the
same patient, sometimes even the same arterial site [7]. Figure 1.1 is a diagram of the
cross-sectional area of two vessels, depicting the difference in appearance between the
two [10].
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Figure 1.1: Diagram of Medial Artery Calcification vs Atherosclerotic Intimal Calcification

1.2.2. Mechanism of Calcification
Vascular calcification is a highly regulated process affected by both systemic
and local factors. Some risk factors for calcification include high serum phosphate,
calcium, or matrix metalloprotease levels, lipid modification, oxidative stress, and
inflammation [17]. Smooth muscle cells seem to be the most studied cell type for the
underlying mechanism of vascular calcification and will therefore be discussed most
frequently in this section. Their ability to change from contractile cells to a proliferative,
synthetic phenotype is critical in many vascular pathologies [18]. The contractile
phenotype seems to be resistant to mineralization and/or apoptosis. Because they are
mesenchymal cells, vascular smooth muscle cells can differentiate into other
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mesenchymal-derived cell types when subjected to stress, such as chondrocytes,
osteoblasts, or adipocytes. This transdifferentiation can lead to altered matrix production,
calcification, and lipid accumulation [8].
MGP is a matrix protein that inhibits calcification and supports the elasticity
properties of smooth muscle cells in normal physiological conditions [28]. It is also
expressed during osteoblastic differentiation of vascular smooth muscle cells and
vascular pericytes [17]. In mice models, it has been shown that the addition of MGP
reduces calcification and atherosclerosis [27] and the absence of MPG causes extensive
arterial calcification, eventually leading to death [26]. The molecular and cellular
mechanisms by which MGP inhibits calcification include: inhibition of vascular smooth
muscle cell transdifferentiation, regulation through the matrix vesicles and apoptotic
bodies, and inhibition of calcium-phosphate precipitates [28]. MGP undergoes serine
phosphorylation and glutamate carboxylation. In order to function in inhibiting vascular
calcification, MGP requires γ-carboxylation, which is driven through the presence of
vitamin K [28]. When there is sufficient vitamin K, contractile vascular smooth muscle
cells produce carboxylated MGP (cMGP), consequentially preventing mineralization
[28]. If there are insufficient levels of vitamin K, and the MGP is uncarboxylated, elastic
fibers can begin to calcify [30] and the vascular smooth muscle cell becomes detached in
the blood vessel [31].

The first stress-induced change of vascular smooth muscle cells is to the
synthetic phenotype, which can proliferate, migrate, and invade the tunica intima. In
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vitro and animal studies show that the initiation of calcification is associated with an
increased uptake of phosphate and calcium by smooth muscle cells [8]. Phosphate enters
the cells through Na-dependent phosphate cotransporters in a concentration and time
dependent manner. Calcium uptake is regulated by calcium-sensing receptors and
voltage-gated calcium channels and is required for the contractility of vascular smooth
muscle cells [8]. In vitro studies have shown that under high calcium conditions vascular
smooth muscle cells undergo apoptosis and release more calcium in the process, which
may result in more apoptosis. Apoptotic bodies form an origin site for calcification [8].
Elevated levels of calcium can induce the mineralization of vascular smooth muscle cells,
even in the absence of osteogenic differentiation [29]. High levels of calcium also lead to
increased activity of matrix metalloproteinase-2 (MMP-2).
Matrix metalloproteinases are associated with the degradation of elastin, a
process observed in most types of vascular calcification [20]. It has been observed in rat
aortic smooth muscle cells that the presence of elastin-derived peptides causes an
increased expression of MMP-2, osteocalcin, and alkaline phosphatase. Gene expression
of osteocalcin and MMP-2 is substantially upregulated by elastin peptides, but does not
seem to be affected by addition of TGF-β1 [20]. Alkaline phosphatase activity increases
when the cells are cultured in media supplemented with TGF-β1 and elastin peptides
more than when cultured with TGF-β1 or elastin peptides alone. This indicates that TGFβ1 and elastin peptides promote calcification of smooth muscle cells in medial
calcification in diabetes [20].
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When vascular smooth muscle cells are in their synthetic form, they also
produce matrix vesicles. If loaded with inactive uncarboxylated MGPs, matrix vesicles
are also more likely to mineralize. Membrane-bound matrix vesicles serve as nucleation
sites for hydroxyapatite, but do not calcify when loaded with the normally present
mineralization inhibitors such as MGP and Fetuin-A [8]. Fetuin is a glycoprotein that is
mainly produced by the liver. It appears to inhibit mineralization through both restricting
hydroxyapatite crystal growth by constraining mineralization within collagen fibrils as
well as by impairing the calcium-phosphate nucleation ability of the matrix vesicles. If
there is a high extracellular calcium level or intracellular calcium release when
calcification inhibitor levels are not high enough, the smooth muscle cells produce
vesicles that are contain preformed hydroxyapatite and alkaline phosphatase. The alkaline
phosphatase inactivates pyrophosphate and osteopontin, inhibitors of hydroxyapatite
crystal formation, and creates additional phosphate sources [8]. The hydroxyapatite
microcrystalline structures and the glycosaminoglycan scaffolds in calcified vessels are
the same as those found in bone tissue.
Medial calcification is associated with mineral imbalances due to a defect in
metabolism. At calcification sites, smooth muscle cells morph to an osteochondrocytic
phenotype and upregulate the expression of mineralization-regulating proteins which are
normally restricted to bone and cartilage tissues [8]. Phosphate is important mineral
involved in the regulation of the osteochondrocytic transdifferentiation. This change
involves downregulation of the smooth muscle cell genes and simultaneous upregulation
of osteochondrocytic genes [8]. A key transcription factor for this process is Runx2. The
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signaling of bone morphogenic proteins (BMP) is involved in the activation of Runx2
transcriptional activity. Bostrom, et al. investigated the effects of diabetes on vascular
BMP signaling activation and found, in vitro, that glucose increased BMP-2 and BMP-4
expression [19]. High levels of fibroblast growth factor 23 (FGF-23) have been
independently associated with increased cardiovascular disease [21]. Compelling
experimental evidence has shown that when FGF-23 is neutralized with antibodies in in
mice models, the result is calcification [Shimada 2004].

FGF-23 is a regulator of

phosphate that is involved the bone tissue homeostasis and secreted by bone cells when it
undergoes glycosylation [23]. When in becomes glycosylated it not only is released from
the cell, but is also protected from being broken down. Due to its role in regulating
phosphate, it could potentially enhance phosphate-induced calcification [24]. Once in
their osteogenic phenotype, vascular smooth muscle cells begin to synthesis bone
regulating proteins, such as osteocalcin, and less MGP [28]. This contributes to the bonelike mineralization seen in calcified vessels.
Endothelial cells are also known to produce MGP, and due their high
concentration in vessels, may be a significant source of MGP [28]. Multipotent vascular
stem cells have also recently been identified, but their contribution to the production of
MGP is not known [32]. Fibroblasts are less studied, but are known to contribute to
calcification. The osteogenic response of fibroblasts in medial vascular calcification is
activated by elastin degradation products and TGF-β1 [25]. In vitro, rat dermal fibroblasts
that were treated with TGF-β1 and elastin degradation products formed multicellular
calcified nodule. These nodules also formed when the cells were treated with each
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separately, but the effect was significantly amplified when used together.

Before

mineralization, the fibroblasts expressed characteristic features of myofibroblasts: α—
smooth muscle actin, collagen type I, and MMP-2. α-SMA is a contractile protein seen in
myofibroblasts (the activated, contractile phenotype of fibroblasts that are capable of
differentiating into calcified vascular cells then osteoblasts). It has been shown that the
migratory myofibroblasts originating from the adventitia respond to smooth muscle cell
osteopontin production and contribute to medial calcification and vascular remodeling in
diabetes [25]. Myofibroblasts are critical in normal tissue repair and typically undergo
apoptosis when the integrity of the tissue has been restored. Their persistence at a site of
injury may be connected to collagen accumulation and calcification [25].
Figure 1.2 is a simplified schematic representing most of the vascular
calcification mechanism described in this section [28]. Other hormones, cytokines, and
cells may contribute to the calcification of vessels as well as those mentioned above, but
the mechanism behind calcification is yet to be completely understood.

11

Figure

1.2:

Mechanism

of

Calcification.

Abbreviations:

p-

and

dp-cMGP/ucMGP;

phosphorylated and dephosphorylated forms of carboxylated and uncarboxylated matrix Gla
proteins, respectively

1.2.3. Biomarkers of Vascular Calcification
Two biomarkers that were analyzed in this study and are indicative of the presence
of calcification in a vessel are osteocalcin and alkaline phosphatase. Osteocalcin, also
known as bone Gla protein, is secreted by osteoblasts and is the most abundant
noncollagenous protein present in bone matrix. It can undergo γ-carboxylation [11].
When osteocalcin is in its γ-carboxylated form, it binds hydroxyapatite [11]. This form of
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the protein is also abundant in the extracellular matrix of bone and calcified vasculature.
Osteocalcin expression is known to be found in calcifying vascular smooth muscle cells,
but the physiological implications of this presence remains unclear [11].
Vascular smooth muscle cells are thought to orchestrate the mineralization in vessels
by osteochondrocytic differentiation within the vessel wall. This differentiation, as well
as the glycolytic metabolism and glucose uptake of vascular smooth muscle cells, is
stimulated by osteocalcin.

It has been demonstrated that osteocalcin mRNA is

upregulated with the onset of vascular smooth muscle cell osteochondrocytic
differentiation and osteocalcin accumulates in calcified vessel walls [12]. Osteocalcin has
recently been recognized for its role in osteochondrogenic differentiation and as an active
modulator of vascular smooth muscle cell signaling. Additional studies are needed to
analyze the relationship between

glucose

metabolism and osteochondrogenic

differentiation. Research to understand the important role of osteocalcin in metabolism
regulation may help to decipher the relationship between metabolic disorders, such as
diabetes mellitus, and vascular calcification.
Alkaline phosphatase is an osteochondrogenic biomarker as well. These enzymes
are present in most organisms and function by catalyzing the hydrolysis of
phosphomonomers, releasing alcohol and inorganic phosphate [13]. Three out of the four
isozymes in humans are tissue specific and the fourth is tissue-nonspecific (TNALP).
TNALP is found in bone tissue as well as human atherosclerotic lesions [13]. Its presence
in the lesions suggests that it may play a role in promoting the accompanying
calcification with the vessel. When TNALP expression is increased, calcification is
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increased in bovine vascular smooth muscle cells [13]. Alkaline phosphatase is present in
most cells as it is involved in cleaving phosphate groups, a common cellular process. An
increase in alkaline phosphatase levels indicates vascular calcification because alkaline
phosphatase promotes calcification by reducing the levels of a medial vascular
calcification inhibitor, pyrophosphate and effectively creating higher phosphate levels.
Alkaline phosphate allows for hydroxyapatite crystal formation as well as the
transdifferentiation of vascular smooth muscle cells.
As previously described, apoptosis is also part of the mechanism of calcification in
that cells that have undergone apoptosis can become mineralized and further the
condition. The biomarker of apoptosis that we focused on is cysteinyl aspartic acidprotease-3 (Caspase-3). When a cell fails to make proper connections or is nutrient
deprived, it undergoes apoptosis. There are several molecular pathways for apoptosis, but
the most common and studied ones are called the intrinsic and extrinsic pathways [33].
Figure 1.3 depicts the extrinsic pathway to the left and intrinsic pathway on the right.
The extrinsic pathway begins with ligand-induced death receptor activation.

There

activation leads to the formation of the death-inducing signaling complex (DISC) within
the cell on the plasma membrane.

This promotes initiator caspase-8, and possibly

caspase-10 to cleave the effector caspase enzymes and proteolytically activate a link
between the pathways called Bid. Bid promotes the mitochondrial membrane
permeabilization seen in the intrinsic pathway [33].
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Figure 1.3. Pathways of apoptosis

The intrinsic pathway of apoptosis begins with intracellular signals leading to
activation within the mitochondria of the cell. Mitochondria develop a higher
permeability in their membranes, allowing the release of cytochrome C. Cytochrome C is
not normally a toxic protein, but can initiate apoptosis through the activation of caspase
enzymes. It first binds and activates Apaf-1 and procaspase-9 to form an apoptosome.
Initiator caspase-9 is then activated, using proteolytic cleavage in order to activate the
caspase effectors Caspase-3 and Caspase-7 [34].
Caspase enzymes act catalytically, only needing a few initiator caspases in order to
activate a large amount of effector caspases. Once activated, caspase enzymes have the
ability to destroy the organelles and chromosomes within a cell.

The presence of

cytochrome C activates one of the caspases, leading to the activation of the caspase
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cascade which starts breaking down all of the cellular components. Apoptosis happens
within the cell membrane because the cell never bursts during the process. The membrane
does, however, begin to express abnormalities that may lead to further reactions [34].
Figure 1.4 is a diagram that simplifies the described mechanism behind the initiation of
apoptosis.

Figure 1.4. Initiation of intrinsic pathway of apoptosis

1.3.

Vascular Cell Mechanics in Arteries
The cells within vasculature throughout the body -endothelial cells, smooth

muscle cells, and fibroblasts- are constantly subject to stresses which activate
mechanotransduction and result in modification of the vessel. Understanding how these
cells interact with their environment within these vessels is imperative in the prevention,
diagnosis, and treatment of vascular diseases. Endothelial cells are found on the inner
wall of blood vessels, lining the lumen. Therefore they are constantly interacting with the
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blood within the vessel. They communicate with the smooth muscle cells within the
media and fibroblasts in the adventitia to regulate vessel function. Smooth muscle cells
contract or relax in order to regulate blood flow.

Adventitial fibroblasts seem to

primarily function as support for the vessel under normal physiological conditions. If the
endothelial cells become damaged or undergo necrosis due to any pathology, the smooth
muscle cells and fibroblast interact directly with the blood. That is why it is important to
understand the impact of cellular interactions and hemodynamic forces on all three cells
within blood vessels.

1.3.1.

Endothelial Cells
Endothelial cells are vital cells in vascular homeostasis. They function as a

permeable barrier and carry out many functions such as: remodeling, proliferation, cell
migration, apoptosis, regulation of contractility of smooth muscle cells in the vessel, as
well as the metabolism, production, and secretion of biochemical substances [14]. In
order to understand the general mechanics and regulation of circulatory function, it is
important to first understand the significant roles of endothelial cells. The endothelial
cells in vasculature are constantly subjected to mechanical stimuli such as fluid shear
stress and stretch. They maintain their intracellular homeostasis using feedback controls
that have been the subject of many genetic, molecular, and cellular studies [14]. In vivo
studies of these mechanisms are advantageous in that the experimental variables can be
controlled. In vivo studies are used to determine the applicability of the information
learned from in vitro studies.
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Endothelial cells line the lumen of vasculature and are constantly subjected to
various fluid shear stresses based on the patterns of blood flow in the body. In vivo,
arterial endothelial cells are characterized by their ellipsoidal shape with the long axes
aligned with the direction of blood flow [15]. The biosynthetic activity, integrity, and
regrowth of endothelial cells following injury are some of the processes that are affected
by the stress applied by blood in vivo. Fluid shear stress is the force produced by a
viscous fluid moving across a solid body which restricts its motion. An increase in the
velocity of a fluid, as well as increased viscosity, cause the magnitude of fluid shear
stress to increase [15]. Fluid velocity increases linearly with distance from the solid
surface so near a plane boundary fluid shear stress can be calculated using the equation
[15]:

where τ is fluid shear stress (dynes/cm2), μ is the viscosity (gm/cm-s = Poise), and
(dv/dz) is the velocity gradient (s-1). Normal fluid shear stresses of the major arteries
during resting condition range between 2 dynes/cm2 and 20 dynes/cm2 [15]Near regions
or sharp curvature and arterial branching localized increases can be seen to about 30-100
dynes/cm2 [15]. In these branched or curved regions there is no well-defined direction to
induce feedback mechanisms in order for the endothelial cells to maintain vascular
homeostasis. The persistence of external stresses can lead to undesired signaling
responses and eventual pathologies [14]. This change in shear stress has raised interest in
the relationship between vessel obstruction and hemodynamics. With researchers
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focusing on the fluid shear stress in vessels, we have been able to come to many
conclusions such as: elevated shear force can damage endothelial cells, histamine
synthesis increases with an increase in shear stress, and flow modifies the repair of
endothelium [15].
Dewey, et al. [15] developed a cone-plate apparatus to study the response of
bovine aortic endothelial cells to various levels of shear stress. For very small flow rates
the specimens experience equal shear fluid shear stresses. For higher flow rates, the outer
specimens experience higher shearing than those closer to the center. In this experiment
they found that the growth kinetics or population of confluent endothelial monolayers
were not significantly altered by 1 dyne/cm2 or 5 dynes/cm2 shear stress. Subconfluent
cultures had a slight tendency of alignment at 5 dynes/cm2. Both confluent and
Subconfluent cultures developed significant time-dependent morphological changes
when exposed to 8 dynes/cm2 for 48 hours and seemed to keep this morphology beyond
48 hours. This study showed that the shape and orientation of endothelial cells is
sensitive to the magnitude of applied shear. Also, confluent cultures seemed to have less
alignment, suggesting that secreted extracellular matrix or cell to cell contact may
influence this behavior. In other experiments it has been shown that morphological
changes in the cell have a direct correlation with reorganization of the endothelial cell
cytoskeleton [15]. Sustained fluid shear stress with a consistent forward direction has
been shown to remodel cytoskeletal fibers to be oriented in the shear flow direction. The
stress fibers are also thickened, the peak cell height shortened, and the cell becomes
stiffened. Cytoskeletal remodeling is not observed when the flow is disturbed [14]. His

19

experiments also emphasized the influence that shear stress can have on the proliferation
and morphology of endothelial cells [15].
In experiments conducted by Chein [14], flow chambers were used to analyze the
effect of shear stress on endothelial cells. They used various cultured vascular endothelial
cells including: bovine aortic endothelial cells (BAECs), human umbilical vein
endothelial cells (HUVECs), and human aortic endothelial cells (HAECs). The channel
was used to create a steady fluid shear rate of 12 dynes/cm2, pulsatile shear at 12 ± 4
dynes/cm2, and reciprocating shear stress at 0.5 ± 4 dynes/cm2. Applying shear stress can
activate a multitude of mechanosensors. Some of these include membrane proteins like
receptor tyrosine kinase, integrins like αvβ3, α2β1, α5β1, and α6β1, G proteins and G proteincoupled receptors, calcium channels, and intercellular junction proteins. Krüppel-like
factor-2 (KLF-2) is expressed in endothelial cells and is beneficial to its survival. Using
the pulsatile shear stress with a significant forward direction compared to the
reciprocating shear stress on HUVECs it was found that both types of shear stress
increased mRNA levels of KLF2 after 1 hour. After four hours there was a drop in the
KLF2 gene expression of endothelial cells with reciprocating shearing. This level
remained low for as long as 24 hours. The pulsatile shear stress sustained upregulation
throughout the testing period. According to this experiment, reciprocating shear stress
applied for 24 hours inhibits expression of KLF2 and reduces the ability of endothelial
cells to survive when subjected to oxidative stress. In contrast, the pulsatile shear stress in
the forward direction is beneficial to endothelial cell survival by allowing continued
expression of KLF2. Further experimentation of HAECs at a steady shear stress of 12
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dynes/cm2 for 24 hours suggests that sustained shearing in a forward direction keeps
endothelial cells from hyperplasia or activating the inflammatory response through the
downregulation of genes related to these functions. Genes involved in angiogenesis and
endothelial cell survival were significantly upregulated by this shear stress [14].
In vivo studies of several animal species have supported the findings of these in
vitro studies. In the straight part of vasculature, stress fibers within endothelial cells are
oriented parallel to the shear stress applied by blood flow. There is little orientation of
endothelial cells at branch sites that are lateral to the vessel dividers, where the blood
flow direction is more disturbed. Partial obstruction in the aorta or common carotid
arteries has been shown to cause a decrease in shear stress downstream of the obstruction
and, consequently, a reduction in endothelial cell elongation and oriented stress fibers.
The reasoning behind this orienting mechanism is that it minimizes the intracellular stress
and strain when there is a continued presence of applied fluid shear stress [14]. Figure
1.3 is a schematic diagram showing the forces acting on the endothelial cells as blood
flows through vasculature [14].
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Figure 1.5: Forces acting on endothelial cells within a blood vessel

The other main stress applied to endothelial cells is the cyclic stretch caused by
pulsating blood pressure in blood vessels. Chien [14] studied the effects of uniaxial and
biaxial stretching on BAECs seeded onto silicone membranes. Both modes of stretch
caused and increase in actin stress fibers, but had different effects of the orientation of the
fibers. Biaxial stretch does not seem to cause the stress fibers to remodel into any specific
orientation whereas the uniaxial stress caused alignment perpendicular to that of the
stretch. If the sample was stretched less than 3%, there was no significant orientation of
the fibers. As the extent of the stretching increases, so does the amount of fiber
orientation. At 10% uniaxial stretch, the cells showed an almost completely perpendicular
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orientation [14]. This is also seen in vivo where arteries are parallel to blood flow and
perpendicular to the stretching force applied from the blood.
The current understanding of the role endothelial cells play in vasculature has
come a long way, but there is still room for improvement. It is known that fluid shear
stress

or

stretch

causes

changes

in

intracellular

mechanics

as

well

as

mechanotransduction. All of these pathways and their interactions still are not completely
understood. It is also known that a clear direction of mechanical stimuli, such as uniaxial
stretch or pulsatile flow, can cause endothelial cell remodeling that may serve to
minimize changes in intracellular stress. This remodeling through mechanotransduction
can also modulate molecular signaling. Some important questions that remain about fluid
shear stress is how the long-term changes in flow rate can cause pathological changes in
blood vessel endothelial cells, which interactions play central parts in these pathologies,
how combinations of the mentioned stresses might affect endothelial cells, and how to
reverse vessel injury and keep endothelial cells in their correct orientation. Further
studies with bioreactors and tissue engineered constructs are beneficial in better
understanding the mechanisms and propose solutions.

1.3.2.

Smooth Muscle Cells and Fibroblasts
Although endothelial cells directly sense the alterations in blood flow and are the

most commonly studied vascular cell in fluid mechanics, smooth muscle cells and
fibroblasts still play a role in regulating vessel function. Endothelial cells detect the
mechanical stimuli then send signals to the cells in the media and adventitia to elicit
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feedback mechanisms. When the endothelial layer of a vessel is damaged, shear stress
may have a direct impact on the medial smooth muscle cells and interstitial flow may be
intensified on vascular smooth muscle cells and fibroblasts. There have been more
studies recently that have investigated and found that interstitial flow and shear stress
significantly influence smooth muscle cells and fibroblasts [16].
The main functions of smooth muscle cells in the middle layer of the arterial wall,
the media, are to regulate and maintain blood pressure, blood vessel tone, and blood flow
distribution [16]. Smooth muscle cells have a high plasticity which allows them to make
reversible changes in their phenotype between a synthetic state and contractile state in
response to external stimuli that is vital for vascular repair and remodeling. Vascular
smooth muscle cells may also contribute to lesion formation by migrating into the inner
layer of the vessel wall when exposed to an abnormal environment, such as vascular
injury [16]. This mechanism is important to study because common procedures such as
angioplasty can injure the intima and cause further pathologies. Following injury,
contractile smooth muscle cells change phenotype to their synthetic state and migrate into
the intimal layer. Adventitial fibroblasts activate to become myofibroblasts and migrate
across the media into the intima. The myofibroblasts and smooth muscle cells then
proliferate and secret extracellular matrix components, eventually forming a neointima
[16].
Medial smooth muscle cells are also exposed to shear stress through interstitial
flow by a pressure difference between the arterial pressure and tissue pressure. The
magnitude of this fluid shear stress is usually very minuscule so it is a much more subtle
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mechanism. Tarbell’s group [16] theorized an estimate for the shear stress from
interstitial flow (τ) to be
τ
where Kp is the tissue’s Darcy permeability, is μ is the fluid viscosity, and U is the
velocity of the superficial flow. This equation does not give an exact value and does not
take into account that smooth muscle cells may experience higher shear stresses when
near the pores due to funneling into the pores [16]. During wound healing of formation of
a vascular lesion, interstitial flow on smooth muscle cells and fibroblasts decreases.
The majority of studies on the effects direct shear stress has on smooth muscle
cells have been in vitro, due to their position within the vessel wall making direct shear
stress difficult to create in vivo. From these studies, mostly done in 2D, it is seen that
fluid shear stress can regulate vasoactive mediators, cytokines, and other signaling
molecules. This is indicative of the important role that smooth muscle cells may play in
vascular homeostasis. There are dramatic differences of cytokine release rates between
smooth muscle cell cultures in 2D and 3D [16]. Because of this fact, we must come up
with more realistic 3D models to properly characterize the behavior of vascular smooth
muscle cells and fibroblasts. Permeability is also an important factor to focus on when
making in vitro models. It is strongly dependent on the matrix material concentration. For
example, the Darcy permeability in 2.5-45 mg/mL collagen gels is about 10-8 – 10-12 cm2,
which is more than two orders higher than the Darcy permeability of a rabbit aortic wall
[16]. This permeability is a significant factor, as seen in the theoretical equation, and
must be considered in future models. A better understanding of the mechanotransduction
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pathways between vascular cells and the extracellular matrix is needed to create better
models for understanding blood vessels and creating tissue engineered solutions. Looking
into the combinations of hemodynamic forces and their effects on smooth muscle cells
and fibroblasts may provide better comprehension of what we must do to treat vascular
diseases. The vascular endothelial cells’ interactions with hydrodynamic forces is
important to explore, but we must not downplay the importance of the other vascular
cells in the process.

1.4.

Current Treatment Options
There is currently no cure for diabetes or vessel calcification. The most

commonly accepted treatments for diabetes focus on managing blood glucose levels.
Patients with type 1 diabetes manage their symptoms using a blood glucose level monitor
with insulin injections, diet to monitor sugar levels, and exercise. The management of
the disease for type 2 diabetic patients includes losing weight, regular exercise, and a
monitored diet [35]. Most drugs that have been created in attempt to cure diabetic
patients of medial calcification do not help, and some have extreme side effects.
Diabetes induced calcification can eventually lead to a need for surgical
procedures in order to replace the affected vessels. Autologous grafts, often the
saphenous vein, are typically the method of surgical intervention, but they may not be
available due to previous uses or morbidity [36]. Other bypass grafts that have been
proposed include xenogeneic grafts and synthetic grafts, but they have limitations such as
thrombosis [36]. Patients with diabetes may also develop critical limb ischemia leading to
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an increased risk of limb loss and mortality after revascularization surgery [38]. Diabetic
patients also have difficulties with percutaneous coronary interventions such as
angioplasty, often resulting in occlusion from restenosis [37].

A higher incidence of

restenosis is also observed when diabetic patients have drug-eluding or bare-metal stents
implanted [39].
Because the mechanism behind calcification in diabetic patients is not known, the
complex interactions with this condition and surgical procedures and biomaterials also
remains unknown. Further research to understanding this mechanism can lead to better
solutions in improving the quality of life for diabetic patients dealing with this ailments.

1.5.

Blood Vessel Tissue Engineering
Tissue engineering is a promising solution for the treatment of blood vessel

pathologies. The goal of tissue engineering is to replace any diseased tissue in the body
with an engineered tissue that can restore function and will regenerate over time. By
combining knowledge from engineering, biology, and material science, it has to potential
to create and repair blood vessels [40]. The currently used synthetic or native grafts are
only effective for large-diameter grafts, due to having a thrombogenic effect in small
diameter grafts [40]. With the availability of autologous material being limited due to
commonly systemic nature of diabetes, affecting sites throughout the vasculature, there is
considerable effort being focused on creating biocompatible prosthetic grafts [40].
The general paradigm of tissue engineering usually begins with cells being
cultured in vitro then seeded on a scaffold made of biological material or synthetic
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polymer [41]. The populated scaffold is then conditioned with mechanical and chemical
stimuli in a bioreactor until there is a sufficient amount of extracellular matrix. The
conditioned construct is implanted into the appropriate area in the body, where it will
remodel in vivo to further mimic the normal functioning tissue or organ [41]. Because
this approach has regenerative properties and the cells integrated are specific to the
patient, there is no need for immunosuppressive drugs as in most cardiovascular implants
[42]. One of the main challenges is to make the vessels that will be resistant to also
acquire the disease from the calcification cytokines present in the diabetic patient. In
order to get to that step, we first need to make a tissue-engineered vessel that will become
completely integrated and functional in the human body. It must be able to withstand the
chemical and mechanical stresses applied to blood vessels every day. Insuring the
preservation of the function of tissue-engineered blood vessels is vital in creating a
sustainable construct.
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Figure 1.6: Tissue-engineered blood vessel scaffolds in a bioreactor. Image and bioreactor from
George Fercana at Clemson University.

1.5.1.

Scaffold-Based Approaches
Bioengineers have been developing and analyzing various materials as possible

vascular scaffolds for years to find the ideal properties for implantation.

The two

categories of scaffolds discussed in this section are synthetic scaffolds and biological
scaffolds. Scaffolds are advantageous in tissue engineering in that they provide a
structure for cells to proliferate on, in contrast to injecting the cells and hoping they form
enough matrix material to stay stationary and resist the mechanical forces in the body.
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Within vasculature, the extracellular matrix is the natural scaffold with proteins to
support the stabilization and organization of cells into the functional blood vessels [43].
Replacing this scaffold while the cells are integrating may be a critical part in the
formation of a tissue-engineered vessel.
Synthetic polymers are unique in their ability to be modified and controlled
consistently during their fabrication. Rate of degradation, strength, and structure are
much more easily modified than in biological scaffolds. The control of their properties is
advantageous when studying the effect of the properties on cells as well as making
vessels with consistent properties. The effect of scaffold structures and rigidity on cell
behavior is one example of their applicability for research purposes [43]. Some examples
of synthetic materials that are used for the synthesis of vascular grafts are polyethylene
terephthalate, polyurethane, expanded polytetrafluoroethylene, polyglycolytic acid, and
poly(lactic acid). Ideally, these polymers would provide the initial mechanical strength
and would resist any adverse reactions in the body [44]. Synthetic polymers have shown
efficacy for large diameter vascular bypasses, but are not suitable for the replacement of
small-diameter vascular tissues.
Although some synthetic scaffolds seem to be viable options for vascular
bypasses, all synthetic materials in the body will eventually undergo some type of
biocompatibility response [42]. This is where biological scaffolds show unique potential
for tissue engineering. Biological scaffolds can be derived from xenogeneic or allogeneic
tissues while removing any cells that may cause an immune response. After being
decellularized, many scaffolds have shown to retain their mechanical properties,
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extracellular matrix integrity, and cell signaling molecules. They can also be comprised
of pure extracellular matrix components. Collagen, fibrin, and elastin are commonly used
biological proteins for creation of vascular scaffolds [44].

1.5.2.

Scaffold-Free Approaches
Scaffold-free approaches have emerged due to the problems that have arisen when

creating tissue-engineered constructs using scaffolds [45]. A few weaknesses of scaffold
approaches are: scaffolds have been linked in reduced cellular communications, the low
strength of gels used may cause the final tissue-engineered vessel to be weak as well, and
residual polymer fragments might disrupt organization of the vessel wall or change the
smooth muscle cell phenotype [45]. Many different techniques have been utilized to
develop a tissue replacement without any scaffold, made only of the native cells and their
matrix components. Despite efforts, scaffold-free tissue-engineering has not had any
clinically applicable solutions yet due to the lack of a reliable mechanism to create
precisely formed tissues [45].
Sheet-based tissue engineering has been one proposed solution to this challenge. It uses
an automated, three-dimensional, computer-aided prototyping machine that deposits
multicellular spheroids into a defined topology from a bioprinter with the aid a substance
such as agarose rods to make a tubular shape. This method also allows for control of the
vessel diameter, thickness, and branching pattern. Although this scaffold free approach
does seem promising, it does have some major challenges to match the mechanical,
biological, and chemical properties to that of the natural vessel [46]. There is yet to be an
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established, plausible solution, but many advancements have been made toward the
creation of artificial blood vessels with or without the presence of a scaffold.

1.5.3.

Requirements for Successful Tissue Engineering
Tissue engineering holds great potential for the treatment of blood vessel

pathologies, such as calcification. One major consideration that must be made in the
development of these solutions is that they should be resistant to the reoccurrence of the
disease complications. The chemistry and mechanical environment present in the body
of a diabetic patient results in the calcification of vessels, so replacing the diseased vessel
with a functional vessel with the same chemistry would likely produce the same outcome.
We must learn more about the mechanism of calcification and develop a way to
counteract the effects of hyperglycemia on blood vessels. Other important considerations
when designing a tissue engineered blood vessel must include biocompatibility of the
construct, its ability to regenerate in vivo, its resistance to degradation, integration into
the vascular system, and restoration of physiological function, including the passage of
gases and nutrients. Significant progress has been made in this field, but much more
research is needed before tissue-engineering results in a long-term viable solution.

1.6.

Rational for Model
The purpose of this research was to better understand the cellular interactions that

mediate vascular calcification in diabetic patients. Our approach was to use Transwell
inserts within 6-well plates to co-culture each combination of the primary vascular cell
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types in diabetic and diabetic media. Calcification in diabetes is known to be, in part,
contributed to the high glucose levels causing cellular changes. This model allowed for
the cells to interact with cytokines and growth factors from the other cell types in high
glucose conditions without have extracellular matrix components to contribute to any
changes. Although the extracellular matrix components have been shown to play a
significant role in calcification, this simplified model allowed for analyzation of the
cellular interactions under high glucose conditions without the influence of these
components. It is relevant to understand how these cells interact when co-cultured,
because they trigger the calcification of the blood vessels through transdifferentiation into
osteoblasts. The short 2 week culture was also to analyze the differences between just the
cells, not other blood vessel constituents. If given more time, the cells start to secrete
extracellular matrix components, which as mentioned, would contribute to calcification.
In summary, this model was created in order to analyze any early modifications that the
interactions of each cell type under high glucose conditions may induce in calcification of
blood vessels in diabetic patients.
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CHAPTER TWO
MATERIALS & METHODS
2.1. Cell Culture
The cells used for this experiment were human coronary artery smooth muscle
cells (HCASMC) (isolated by Lonza), human aortic endothelial cells (HAEC) (isolated
by Lonza), and human aortic adventitial fibroblasts (HAoAFB) (isolated by Lonza). All
of the specialized cell media were from Lonza: the SmGM-2 Bullet Kit (#CC-3182) for
HCASMCs, the EGM-2 Bullet Kit (#CC-3162) for HAECs, and the SCGM Bullet Kit
(#CC-3205) for HAoAFBs. Each cell type was cultured separately for 1 week in their
respective specialized medium. After there was enough of each cell type to cover 3,500
cells per square centimeter of the culturing surfaces, they were switched to the 6-well
plates with Dulbecco’s Modification of Eagle Medium (DMEM, Corning-Cellgro).
The media that represented diabetic conditions was 1X DMEM with 10% fetal
bovine serum (FBS), 1% antibiotic solution (Corning – Cellgro) , and 5.5 g/L glucose
(added 4.5 g/L D-(+)-Glucose Monohydrate (#1.08342.1000, EMD Chemicals)). The
control media did not have additional glucose added, only the 1 g/L of glucose that comes
in the 1X DMEM. Each combination of cell groups was co-cultured in pairs with
alternation of one cell type on the membrane of the 6-well Inserts with 0.4 μm pores
(#29442-104, VWR Scientific) and the other cell type on the bottom of the sterile 6-well
plate included with these inserts. A total of 24 diabetic well and insert groups were cocultured and 24 non diabetic well and insert groups. All of the cells were co-cultured in
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the well and membrane systems for 2 weeks with removing half the media and adding
fresh media every 3 days.

2.2.

Immunofluorescence
After the cells were co-cultured for 2 weeks, the cells were stained to observe the

presence of caspase-3, osteocalcin, and alkaline phosphatase. To do this, four more 6well plates were labeled according to the membrane groups 1-24 to store the membranes
for staining. Using sterile forceps, the Transwell inserts were transferred to the new
plates. Each polycarbonate membrane was cut out from the insert onto the bottom of the
well using a sterile scalpel by pressing the blade against the edge and slowly turning the
insert in the well to cut out the circular bottom. Next, the media was taken from each well
and stored for MMP analysis. All of the wells were rinsed with 2 mL of 1X PBS then
fixed with p-formaldehyde for 30 minutes. They were then rinsed with 1X PBS three
times and then permeabilized with 0.2% Triton for 5 minutes at room temperature. The
wells were rinsed again three times with 1X PBS and blocked with blocking solutions
(5% bovine serum albumin, 0.05% Triton, 94.95% 1X PBS) for 2 hours at 4˚C. The
blocking solution was removed and the primary antibodies: mouse monoclonal [OCG3]
to osteocalcin (#ab13420, Abcam), mouse monoclonal to caspase-3 (#MA1-16843,
ThermoFisher Scientific), and rabbit polyclonal to alkaline phosphatase (#ab65834,
Abcam), were diluted according to the manufacturers’ specifications in blocking solution
before being added to the wells at 4˚C overnight.
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The primary antibodies were then recovered and the wells were rinsed three times
with 1X PBS. The lights were turned off and the secondary antibodies were diluted 5
μg/mL in blocking solution to add 0.7 mL of each solution per well. Donkey anti-mouse
IgG Alexa Fluor 594 (#A-21203, ThermoFisher Scientific) was added to the wells with
the caspase-3 primary antibody. Donkey anti-mouse IgG Alexa Fluor 488 (#A-21202,
ThermoFisher Scientific) and donkey anti-rabbit IgG H&L Alexa Fluor 594 (#ab150076,
Abcam) were added to the wells that were being stained for both osteocalcin and alkaline
phosphatase presence. The secondary antibodies were left on the cells in the dark for one
hour while the well plate was on a shaker. After the incubation period, the secondary
antibodies were removed and the wells were washed three times with 1X PBS. Enough
DAPI solution (#D9542, Sigma) was added to cover the bottom of each well for 2
minutes before the cells were rinsed a final time with 1X PBS and stored in PBS with the
plates wrapped in Parafilm M and aluminum foil until they were imaged via fluorescence
microscopy.

2.3.

Alizarin Red Staining
Alizarin Red Solution was obtained and adjusted to a pH of 4.1. The 1X PBS that

the cells were stored in was removed from each well. The wells were then rinsed twice
with ddH2O. The ddH2O was completely removed and 2 mL of Alizarin Red Solution
was added to each well. The plates were placed on a rotator and incubated at room
temperature for 20 minutes. After the dye was removed, the wells were washed 5 times
with ddH2O. Then, the ddH2O was removed and 1:1 dilution of hematoxylin and ddH2O
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was added for one minute. Each surface was then rinsed five more times with ddH2O and
stored in ddH2O with the plate covered with Parafilm M until each group could be
imaged using light microscopy.

2.4.

Protein Extraction
In order to extract proteins from the samples, a RIPA Buffer extraction procedure

was used. First, four separate 6-well plates had to be labeled in order to keep up with the
Transwell membranes. Using sterile forceps, the Transwell inserts were transferred to the
new plates. Each polycarbonate membrane was cut out from the insert onto the bottom of
the well using a sterile scalpel by pressing the blade against the edge and slowly turning
the insert in the well to cut out the circular bottom. The RIPA buffer that was made
consisted of 50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1%
Sodium Deoxycholate, and 0.1% SDS. The buffer was adjusted to a pH of 7.4 and 10uL
of Sigma P-8340 protease inhibitor cocktail per mL of RIPA Buffer was added right
before use. The media was taken out from each well and stored for MMP analysis. Then,
2 mL of 1X PBS was added to each well. The PBS was aspirated off and 500 μL of RIPA
Buffer was added to each well. Using a different rubber policeman for each group, the
cells were thoroughly disturbed by scraping each membrane and well bottom in every
direction all over the surface. Then the solution for each group was placed into a labeled
2 mL conical tube, mixed with a vortex, then put in a 4˚C refrigerator for one hour.
Following the incubation period, the samples were spun down using a centrifuge at
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12,000 x g for 15 minutes. The supernatant was removed from the samples and stored in
a 1.5 mL conical tube with a closed cap at 80˚C until the samples were analyzed.

2.5. Total Protein Assay
A microplate bicinchoninic acid (BCA) assay was used to quantify the
concentration of proteins in each sample. To do this, a Pierce Biotech (Rockford, IL) kit
was used. Six diluted albumin standards were prepared at concentrations ranging from 02000 μg/mL and then inserted into a 96 well plate in order to create a standard curve.
After the standards, 25 μL of each sample was also inserted into the 96 well plate. The
BCA Working Reagent (WR) was mixed with 34.3 mL of Reagent A and .7 mL of
Reagent B in order to add 200 μL of WR per well. The plate was then mixed on a shaker
for 30 seconds and moved to incubate at 37˚C for 30 minutes. After the plates were
cooled to room temperature the absorbance was measured at 562 nm.
This procedure was repeated for the protein analysis, because the concentrations
were too low. Before repeating the BCA assay, the proteins were concentrated by a factor
of 12x through to use of Amicron Ultra-0.5 Centrifugal Filter Unit with Ultracel-10
membrane (#UFC501096, Millipore). The filter devices were inserted into a
microcentrifuge tubes and up to 500 μL of a sample was added into each filter device.
Next, the filter device was capped and centrifuged for 10 minutes at 14,000 x g with the
cap straps aligned towards the center of the rotor. The assembled devices were removed
from the centrifuged and separated from the microcentrifuge tube. To recover the newly
concentrated solute, the filter device was placed upside down in a clean microcentrifuge
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tube with a cap and centrifuged for 2 minutes at 1,000 x g. The ultrafiltrate was stored
into the centrifuge tube until the BCA Assay was performed.

2.6.

Western Blot
To prepare the samples, the volume of sample solution need for a concentration of

20 μg of protein per well was calculated from the BCA assay. The concentration of nonreducing sample buffer and volume to bring all samples to the same volume was
calculated as well. There was about 42 μL of each sample and buffer solution total, so 2.1
μL of beta-mecraptoethanol (BME) was added to each sample mixture. The 2 mL conical
tubes were then locked shut and placed in a stand to boil for 5 minutes. During this time,
the electrophoresis chamber was assembled. The Mini-PROTEAN TGX Gels (#4561084, Bio-Rad) were placed into the chamber after the comb was removed from the top
and sticker from the bottom. The electrophoresis module was filled with 1X
electrophoresis buffer (diluted with ddH2O from 10X buffer: 25 mM Tris, 192 mM
glycine, 0.1% SDS).
After the samples had finished boiling for 5 minutes, 45 μL of each sample was
added in the lanes as well as 45 μL of 1X sample buffer and 10 μL of the molecular
weight standard (#161-0375 Precision Plus Protein Standards, Kaleidoscope, Bio-Rad).
The gel electrophoresis was ran for 35 minutes at 200 V with the module surrounded by
an ice bath. While the electrophoresis was running, the polyvinylidine fluoride (PVDF)
membrane was prepared for each gel. To do this, a sizing jig was used to cut out the
correct size from a large roll of PVDF. The membrane was never touched, only the outer
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blue sheets covering the membrane. The PVDF membrane was removed from the outer
sheets with a pair of plastic tweezers from the corner of the membrane. A small cut was
made on the bottom left corner of the membrane to keep up with the orientation. Then the
membrane was placed in 100% methanol for 20 seconds, ddH2O for 2 minutes, and
transfer buffer (to process 2 gels made 4L of ddH2O with 6.06g Tris, 28.8g Glycine,
200mL methanol) for at least 5 minutes. The membrane was lightly pressed into the
liquid to keep it submerged if needed during these soaks.
When the gels were done with the electrophoresis cycle, they were removed from
the module. Each gel was carefully removed from the glass plates covering the gel. The
borders of the gels were cut away before the gels were placed in individual containers
containing transfer buffer and allowed to cool to room temperature for 15 minutes.
During the equilibration time, the electrode holder box was washed in order to remove
SDS before it could be used with the transfer cell and Tris buffer (50 mM Tris (12.1g),
150 mM NaCl (17.52g), 2L of ddH2O, pH 7.5) was made if it had not been made ahead
of time. After the gels were cooled, the gel sandwiches could be made for transferring the
protein to the PVDF membrane. This sandwich consists of 1 cassette, 1 PVDF
membrane, 2 filter papers, and 2 fiber pads per gel. All of the components were presoaked with transfer buffer in a Pyrex pan. The gel sandwich was stacked from the black
side of the cassette up, in the following order: pre-wetted fiber pad, pre-wetted filter
paper, gel, PVDF membrane, pre-wetted filter paper, pre-wetted fiber pad, then the clear
side of the cassette was on top. Once the stacking was complete, a serological pipette was
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rolled over the top fiber pad in order to remove any air bubbles before the cassette was
closed tightly.
The gel sandwich pas placed into the transfer cell with the black side of the
cassette facing the black side of the transfer cell. Then the transfer cell was placed into
the clean electrophoresis module filled with transfer buffer and containing an icepack and
small stir bar in the center. Next, the module was placed in a bucket full of tightly packed
ice, half filled with water. With the stir bar spinning and the module hooked up to the
power source, the electrophoresis module ran for 60 minutes at 100 volts. During this
time, the 2% non-fat dried milk (NFDM) solution (2% NFDM in 200 mL Tris Buffer)
was made. When the run was complete, all solutions were allowed to equilibrate to room
temperature. Before blocking, the membranes were carefully removed from their gel
sandwiches. The side that was facing the gel was marked with L1 or L2 in pencil and
kept facing upward for the remainder of the steps.
To block the blots they were each placed in their own container with 50mL of 2%
NFDM for one hour on a shaker. Next, they were incubated overnight at 4˚C while
shaking in 25 mL each of primary antibody solution (1 μg/mL of donkey anti-mouse IgG
Alexa Fluor 488 (#A-21202, ThermoFisher Scientific), 1 μg/mL of donkey anti-rabbit
IgG H&L Alexa Fluor 594 (#ab150076, Abcam), 50mL of 2% NFDM solution).
Following the incubation period, the primary antibody solutions were removed and
frozen to reuse for the next western blot. The membranes were then washed three times
for 15 minutes each wash in 100 mL of Tris-Tween solution (1 mL of Tween20 (EM
Science) in 1 L of Tris buffer). They were placed in different containers and washed two
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times for 12 minutes in 50 mL of 0.5% NFDM diluted in Tris solution on a shaker. The
next step was to incubate the membrane for 90 minutes with shaking in 30 mL/blot of a
secondary antibody solution (3.6 μL in 60 mL 1% NFDM, secondary antibody from BM
Chemiluminescence Western Blotting Kit (Mouse/Rabbit), Roche Diagnostics). Then the
membranes were washed four more times for 15 minutes in 100 mL of Tris-Tween
solution. They were transferred to a new container in Tris buffer and moved to be
imaged. A detection solution was prepared and stored in the dark consisting of 250 μL of
starting solution B of the BM Chemiluminescence Western Blotting Kit and 25 mL of
substrate solution A from the kit. The Bio-Rad imager was used to capture an image of
each blot.

2.7.

MMP Detection
First, a microplate BCA assay was used to quantify the protein concentration in

each media sample. Gelatin zymography was then performed in order to quantify the
amount of MMPs in each media sample. Premade 10% Ready Gelatin Zymogram Gels
(#1611167, Bio-Rad) were used for this procedure. First, the collected media was thawed
in a 37˚C water bath for 30 minutes. Next, samples were mixed 1:2 with the 1x nonreducing sample buffer (3.55 mL distilled water, 1.25 mL of 0.5 M Tris-HCl, 2.5 mL
glycerol, 2 mL of 10% SDS, 0.2 mL of 0.5% Bromophenol Blue) according to the
volume that was calculated from the BCA assay. Each sample was then loaded onto the
gel lanes with a standard (Bio-Rad prestained protein marker) and 1x non-reducing
sample buffer solutions in any of the lanes that were empty. The gels were then loaded
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into a Bio-Rad (Hercules, CA) electrophoresis apparatus filled with 1X electrode buffer
(diluted with ddH2O from 10x buffer: 25 mM Tris, 192 mM glycine, 0.1% SDS) that was
submersed in a cooler filled with ice. The apparatus was ran at 90V for 90 minutes. After
the gels were removed from the apparatus, they were washed with 100 mL of 2.5%
Triton X-100 for 30 minutes for 30 minutes in order to remove the SDS. The gels were
moved to a closed container with development buffer (50 mM Tris-HCl, pH 7.5, 200 mM
NaCl, 0.2% Brij-35, 5 mM CaCl2) and incubated on a shaker overnight at 37˚C. The next
day, the gels were stained with 40% methanol, 50% water, 10% glacial acetic acid, and
0.5% Coomassie Brilliant Blue R-250 (#161-0400, Bio-Rad) for 45 minutes. The gels
were destained with 40% methanol, 10% acetic acid, and 50% water for 2 hours (until the
clear bands formed on the blue background and standards were visible), changing the
solution every 30 minutes. The gels were then photographed using the Bio-Rad digital
camera under the “light bands” setting.
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CHAPTER THREE
RESULTS
3.1. Experimental Groups
The experimental groups for analyzation of the cellular interactions were
organized into the interactions shown in Figure 3.1. The goal of this organization was to
compare interactions in media with a high glucose level vs normal media.

Cell Co-Culture
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Analyzed Cells on
Membrane
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Levels
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Well Plate
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Figure 3.1. Schematic of Experimental Groups
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3.2 Alkaline Phosphatase Expression
Alkaline phosphatase is involved in cleaving a calcification inhibitor during
vascular calcification, and was one of the calcification biomarkers that was a focus of this
research. Immunostaining works through the binding of primary and secondary
antibodies. Antibodies are molecules produced by the body’s immune system in order to
recognize foreign proteins to be removed from the body. An antigen is the molecule
which is recognized and tagged by the antibody. The part of an antigen that is recognized
is called the epitope. Once the antibody is allowed to attach to the epitope on the antigen,
the secondary that is conjugated with a fluorescent molecule binds to the primary
antibody to create the positive signal in images. After the proteins are tagged for alkaline
phosphatase, immunofluorescent imaging was performed at a magnification of 20X to
obtain the following pictures.
The first set is the vascular smooth muscle cells that were co-cultured with the
other cell types, as indicated to the left of the images, and the second is the adventitial
fibroblasts. The red color signifies a positive stain for the protein, with the blue DAPI
stain showing where the cell nuclei are. All of the groups stained positive for alkaline
phosphatase presence. This could be because alkaline phosphatase is involved in cleaving
phosphate groups, which is a common cellular process in all cells. If the cells were in
culture for a month with high glucose levels, it has been shown that there would be a
higher presence more in the diabetic group. We did this in order to see if there were early
modifications, which did not seem apparent based on the images.
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Figure 3.2. Expression of alkaline phosphatase in vascular smooth muscle cells. The top
four images are SMCs cultured on the Transwell membrane interacting with the other
cell type signified to the left of the images cultured on the bottom of the well. The
bottom four images are SMCs cultured on the bottom of the well plate with the other
cell types signified to the left of the images cultured on Transwell membrane.
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Figure 3.3. Alkaline phosphatase expression in adventitial fibroblasts. The top four
images are FBs cultured on the Transwell membrane interacting with the other cell
type signified to the left of the images cultured on the bottom of the well. The bottom
four images are FBs cultured on the bottom of the well plate with the other cell types
signified to the left of the images cultured on Transwell membrane.
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A Western Blot was done in order to quantify the amount of alkaline phosphatase
and osteocalcin that were present in the cells. Instead of using a protein in the wells with
a known concentration, we normalized each solution to 20 ug/mL, so each well had the
same amount of protein. The osteocalcin was not visible from this assay, but the pictures
of the blots and corresponding densitometric analyses of alkaline phosphatase (molecular
weight about 57-66kDa) for each sample are shown in Figure 3.4, Figure 3.5, Figure
3.6, and Figure 3.7. Although there didn’t seem to be apparent differences from the
immunofluorescence images, we can observe some quantifiable differences from this
technique.
In Figure 3.4, we can see that the fibroblasts on the well surface produced more
alkaline phosphatase than any other cell type—the highest level of alkaline phosphatase
being produced by the fibroblasts cultured with smooth muscle cells in diabetic media.
There did not seem to be any significant differences in the alkaline phosphatase
production of the other groups cultured in diabetic media on the well plate surface
(Figure 3.4). When comparing these results to the relative alkaline phosphatase levels in
Figure 3.5, we can see that when cultured in nondiabetic media, the fibroblasts
cocultured with endothelial cells did not have as much alkaline phosphatase activity as
when cultured in diabetic media. The fibroblasts that were cultured with smooth muscle
cells were still the group which produced the most alkaline phosphatase, but this alkaline
phosphatase production from this interaction seems to be less dependent on glucose
levels.
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Figure 3.6 indicates that the group with the most alkaline phosphatase on the
Transwell membrane in diabetic conditions was the smooth muscle cells cultured with
endothelial cells. This data supports publications that indicate endothelial cells produce
cytokines to induce the transdifferentiation of smooth muscle cells in calcification as well
as the thought that smooth muscle cells are a key cell in transdifferentiation to osteoblasts
in high glucose levels [28]. An also notable comparison is that the smooth muscle cells
that were cultured with fibroblasts and fibroblasts cultured with endothelial cells showed
higher levels of alkaline phosphatase compared to the other groups. A surprisingly low
alkaline phosphatase level is seen in the fibroblasts that were cultured with smooth
muscle cells. This was one of the two groups that displayed positive expression of
osteocalcin in the images shown in the next section.
Blot 4, which is presented in Figure 3.7 had lower intensity volumes overall, so
the image may not be as reliable. This analysis indicated that in the normal media, the
group with the highest expression of alkaline phosphatase was the fibroblasts cultured
with smooth muscle cells. This is consistent with the results from Figure 3.5, where they
were cultured in nondiabetic media on the well plate surface. Also consistent with the
results from the well plate surface data, is that the fibroblasts cultured with endothelial
cells have lower levels of alkaline phosphatase comparted to the other groups than they
did in the diabetic cultured membrane surfaces.
These quantitative analyses made comparisons possible that were not evident in
the images.
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Alkaline Phosphatase Blot 1 – Diabetic Media, Well Surfaces

75 kDa

EC+FB

FB+EC

SMC+FB SMC+EC EC+SMC FB+SMC

Figure 3.4. Diabetic Media, Well Surface Groups for Western Blot. Western blot membrane and
corresponding densitometric analysis for the presence of alkaline phosphatase for cells cultured in
diabetic media on the well plate surface. The first acronym in each group represents the cell
cultured on the membrane surface above the analyzed cell type and the second acronym
represents the cell type on the surface of the well plate.
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Alkaline Phosphatase Blot 2 – Control Media, Well Surfaces

75 kDa

EC+FB

FB+EC

SMC+FB

SMC+EC

EC+SMC

FB+SMC

Figure 3.5. Nondiabetic Media, Well Surface Groups for Western Blot. Western blot membrane
and corresponding densitometric analysis for the presence of alkaline phosphatase for cells
cultured in nondiabetic media on the well plate surface. The first acronym in each group
represents the cell cultured on the membrane surface above the analyzed cell type and the second
acronym represents the cell type on the surface of the well plate.
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Alkaline Phosphatase Blot 3- Diabetic Media, Membrane Surface
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Figure 3.6. Diabetic Media, Membrane Surface Groups for Western Blot. Western blot
membrane and corresponding densitometric analysis for the presence of alkaline phosphatase for
cells cultured in diabetic media on the Transwell membrane surface. The first acronym in each
group represents the analyzed cell type cultured on the membrane surface and the second
acronym represents the interacting cell type on the surface of the well plate below the analyzed
cell type.
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Alkaline Phosphatase Blot 4 - Control Media, Membrane Surface
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Figure 3.7. Nondiabetic Media, Membrane Surface Groups for Western Blot. Western blot
membrane and corresponding densitometric analysis for the presence of alkaline phosphatase for
cells cultured in nondiabetic media on the Transwell membrane surface. The first acronym in
each group represents the analyzed cell type cultured on the membrane surface and the second
acronym represents the interacting cell type on the surface of the well plate below the analyzed
cell type.
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3.3. Osteocalcin
The next images are the only groups that stained positive for both alkaline
phosphatase in red and osteocalcin in green. The calcification biomarker, osteocalcin,
was only seen in two groups. Both groups were cultured in diabetic media, the positive
cell type cultured on the membrane, and caused by an interaction between smooth muscle
cells and fibroblasts. The first image is the HCASMCs cultured on the membrane of the
Transwell inserts with the fibroblasts on the bottom of the well plate below them cultured
in diabetic media.

Figure 3.8. HCASMC in conditions expressing osteocalcin and alkaline phosphate. This is an
image taken of the vascular smooth muscle cells cultured on the membrane of the Transwell
inserts with the fibroblasts on the bottom of the well plate below them cultured in diabetic media
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The other group that had positive expression of both biomarkers was also in
diabetic media and with the interaction of vascular smooth muscle cells and fibroblasts,
but in this case, the fibroblasts were the cells with osteocalcin expression. This suggests
that the interaction of these two cell types under hyperglycemic conditions in the body
may contribute to vascular calcification in diabetes.

Figure 3.9. HAoAFB in conditions expressing osteocalcin and alkaline phosphate. This is an
image taken of the adventitial fibroblasts cultured on the membrane of the Transwell inserts with
the smooth muscle cells on the bottom of the well plate below them cultured in diabetic media.
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3.4. Caspase-3
All of the caspase-3 immunofluoresent images shown were taken at a
magnification of 20X and are representative of each group. The groups of images shown
below are the immunofluorescent stain for caspase-3, the enzyme involved in apoptosis
execution. We chose to focus on the caspase-3 enzyme because it is a main effector in
apoptosis of vascular cell and is one of the last caspases in the cascade. The first set of
images are of the vascular smooth muscle cells that were co-cultured with the other cell
types and the second is the adventitial fibroblasts. Again, the red color signifies a positive
stain for the protein, with the blue DAPI stain showing where the cell nuclei are.
All of the cells, regardless of culturing conditions, seemed to be undergoing
apoptosis. We had not performed this culturing technique before, so it needs to be
optimized in order to avoid apoptosis. One theory of why apoptosis was initiated is that
the cells were not able to get enough oxygen. This would activate the intrinsic pathway of
apoptosis through intracellular signaling. The cells would probably also benefit from
fluid flow across the surface since that is seen in the physiological conditions, so putting
the 6-well plates containing the Transwell membrane on a shaker with slight circular
movement while they incubate may help prevent apoptosis if this study were to be
repeated. When the media is rotating around the well and membrane, the distance from
the cells to the oxygen source (air) would be shorter on the opposite side that the shaker
is tilting towards.
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Figure 3.10. Vascular smooth muscle cells undergoing apoptosis. The top four images
are SMCs cultured on the Transwell membrane interacting with the other cell type
signified to the left of the images cultured on the bottom of the well. The bottom four
images are SMCs cultured on the bottom of the well plate with the other cell types
signified to the left of the images cultured on Transwell membrane.
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Figure 3.11. Adventitial fibroblasts undergoing apoptosis. The top four images are
FBs cultured on the Transwell membrane interacting with the other cell type signified
to the left of the images cultured on the bottom of the well. The bottom four images
are FBs cultured on the bottom of the well plate with the other cell types signified to
the left of the images cultured on Transwell membrane.
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3.5.

Calcium Analysis
The stain that was performed for qualitative analysis of calcium deposits was

Alizarin Red Solution. It forms a complex with calcium through chelation and produces
red refraction indication the presence of calcium. This stained positives in all groups as
well because anything stained signifies a calcium in the cell, not just calcium phosphate
crystals in calcification. We expected to see cell clusters and calcium accumulation in the
groups, but did not see this with 2 weeks of culture.

Control

Diabetic

SMC on
Plate

With EC

With FB

Figure 3.12. Calcium deposits in vascular smooth muscle cells. The samples were
imaged using light microscopy. The four images are SMCs cultured on the bottom
of the well plate with the other cell types signified to the left of the images cultured
on Transwell membrane. Red signifies the presence of calcium deposits.
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Figure 3.13. Calcium deposits in adventitial fibroblasts. The cells were imaged
using light microscopy. The four images are FBs cultured on the bottom of the
well plate with the other cell types signified to the left of the images cultured on
Transwell membrane. Red signifies the presence of calcium deposits.

3.6.

MMP Detection
Gelatin zymography was performed in order to analyze the matrix

metalloprotease content of the media from each group. There were no MMPs seen in any
of the groups (Figure 3.14), but this is not indicative that there may not be any in the
media, it is most likely due to an error when executing the procedure.

In

order

to

analyze protein content before the gelatin zymography and Western Blots, BCA assay
was performed, then, a standard curves were generated that displayed the total protein
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concentration that corresponded to each absorbance. The data acquired experimentally
for the media samples and surface extracted samples was then normalized with the use of
the BCA standard curves (Figure 3.15 and Figure 3.16).

Figure 3.14. Zymography gel with standard on left edge

Figure 3.15. BCA standard curve for media samples
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Figure 3.16. BCA standard curve for surface extracted samples
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CHAPTER FOUR
DISCUSSION & CONCLUSION
4.1.

Discussion
Our approach to understanding the cellular interactions underlying vascular

calcification in diabetic patients was effective in some aspects, but could also be
improved. We co-cultured each combination of vascular smooth muscle cells, fibroblasts,
and endothelial cells on Transwell membrane surfaces and bottom of well plate surfaces
under high glucose levels and compared them to the same groups in nondiabetic
conditions. To observe the interactions, we performed immunofluoresent and Alizarin
Red Solution staining, Western blots, and gelatin zymography.
The rationale behind the staining was to see if we could observe the presence of
calcification markers, from imaging. The caspase-3 staining shows if the cells undergo
apoptosis, which they did, but could be a marker of calcification if the apoptosis is due to
high levels of calcium. There was no observed differences in the co-culture groups so the
apoptosis was probably due to a lack of nutrients. The Alizarin Red Solution stain was
performed to analyze the presence of calcium. High levels of cytoplasmic calcium can
also cause calcification, and is therefore a biomarker of calcification. We expected to see
the cells in clusters and calcium accumulations, but it was possibly too early to see this
modification.
Osteocalcin is a bone protein and signifies transdifferentiation to an osteogenic
phenotype. Based on the immunofluoresent images (Figure 3.8, Figure 3.9), vascular
smooth muscle cells and fibroblasts transdifferentiate to an osteogenic phenotype when
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exposed to high glucose levels and specific media components secreted from the other
cell type. It has been shown that fibroblasts express bone-regulating proteins when
exposed to deteriorated matrix environments that would be present in calcification [25].
They may do this, first, through transformation to myofibroblasts under stress and
eventually osteoblasts [47]. This means that they play a role in calcification, but it has not
been shown that they can express these bone proteins under high glucose levels—a
missing link may have been the smooth muscle cells are activating them through a
paracrine mechanism in the presence of elevated glucose levels.

There is in vivo

evidence to support that alterations in signaling molecules can affect smooth muscle cell
function and other cell types through a paracrine mechanism [16].
Alkaline phosphatase cleaves calcification inhibitors and is, therefore, also a
biomarker of calcification. We did not see any differences based on the images, so looked
to quantitative analysis for more information.

To further analyze the calcification

biomarker expression shown in the images, we did a Western Blot. The western blot did
not show up for osteocalcin, this may have been to the “gel sandwich” not being
completely submerged in solution during assembly, causing bubbles during the transfer
of protein expression to the membrane. The alkaline phosphatase data did show up and
was able to be used in order to compare activity between the co-culture groups.
In nondiabetic media, the fibroblasts co-cultured with endothelial cells did not
have as much alkaline phosphatase activity compared to the other groups as when
cultured in diabetic media (Figure 3.4, Figure 3.5, Figure 3.6, and Figure 3.7). This
data is suggestive that high glucose levels may induce endothelial cells to release
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cytokines that initiate an osteogenic phenotype in fibroblasts. Co-cultures of fibroblasts
and endothelial cells have been studied before in order to understand angiogenesis
interactions, with seeing that they do affect each other [48]. Other in vivo studies have
shown that active adventitial fibroblasts, myofibroblasts, contribute to the formation of a
neointima following vascular injury [16] and can undergo proliferation, dramatic
phenotype changes, and migration [16]. In multiple setups of the different co-cultures
(Figure 3.4, Figure 3.5, Figure 3.7) fibroblasts that were cultured with smooth muscle
cells were still the group which produced the most alkaline phosphatase, so alkaline
phosphatase produced from this interaction seems to be less dependent on glucose levels
and may be due to another paracrine mechanism where smooth muscle cells since
environmental signals (or lack of) and initiate the transdifferentiation of fibroblasts. This
hypothesis is supported by the Western Blot shown in Figure 3.6, where there are
surprisingly low alkaline phosphatase levels under diabetic conditions. The images
showed that this group, specifically when cultured on the membrane, had positive
expression of osteocalcin. That means that the fibroblast had changed to an osteogenic
phenotype, at least to some degree, even though the alkaline phosphatase levels weren’t
as high.
When cultured in diabetic conditions and on the Transwell membrane surface (the
most reliable surface for receiving signals from the cell below) the group with the most
alkaline phosphatase was the smooth muscle cells cultured with endothelial cells. This
data supports publications that indicate endothelial cells produce cytokines to induce the
transdifferentiation of smooth muscle cells in calcification as well as the thought that
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smooth muscle cells are a key cell in transdifferentiation to osteoblasts in high glucose
levels. Endothelial cells most likely play a key role in any pathology of blood vessels
because they are in direct contact with the blood and the pressures, cytokines, hormones,
and proteins that accompany it. This is why this study should be performed again with
different media for co-culturing. If this study is conducted again, it would also be
beneficial to run the same cell co-cultures on the same Western Blots in order to get a
more accurate comparison. This was broken up based on the media conditions, which is
not beneficial due to the comparison only being a relative amount of proteins within each
blot. The endothelial cells were apoptotic before they were analyzed, so we could not
retrieve any images or quantitative analysis from these important cells.
This study was conducted in order to see early modifications of the cells, but after
they are transdifferentiated into osteoblasts they initiate the calcification of extracellular
matrix components, such as elastin and collagen. After there is a better understanding of
the early modifications, it is important to understand the role of the cellular-extracellular
matrix interactions as well.

4.2.

Conclusions
This research highlights the importance of studying cellular interactions within

the blood vessels in order to further define the mechanism of calcification in diabetic
patients. This approach was effective because it did not include ECM components, which
also play a large role in calcification, in order to focus solely on the interactions of the
cells in high glucose conditions. These results show novel information about
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modifications of fibroblasts and smooth muscle cells when co-cultured in diabetic
conditions. Differences between the alkaline phosphate levels of each co-culture group
were not apparent based on the immunofluorescence qualitative analysis but, through the
use of Western Blot analyses, we were able to compare the intensity volumes between the
groups.
Based on the immunofluorescence images (Figure 3.8, Figure 3.9), vascular
smooth muscle cells and fibroblasts transdifferentiate to an osteogenic phenotype when
exposed to high glucose levels and specific media components secreted from the other
cell type. In nondiabetic media, the fibroblasts cultured with endothelial cells did not
have as much alkaline phosphatase activity compared to the other groups as when
cultured in diabetic media (Figure 3.4, Figure 3.5, Figure 3.6, and Figure 3.7).
Fibroblasts that were cultured with vascular smooth muscle cells produced the most
alkaline phosphatase, regardless of the level of glucose in culture media, but only
secreted osteocalcin when exposed to high glucose levels.
In diabetic conditions and on the Transwell membrane (the most reliable surface
for receiving signals from the cells below) the group with the most alkaline phosphatase
was the smooth muscle cells cultured with endothelial cells. This data supports
publications that indicate endothelial cells produce cytokines to induce the
transdifferentiation of smooth muscle cells in calcification as well as the thought that
smooth muscle cells are a key vascular cell in transdifferentiation to osteoblasts when
exposed to high glucose levels.
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4.3.

Future Directions
For future studies, I would first recommend redoing this 2D co-culture study with

a different type of medium (such as phenol red-free DMEM supplemented with 2% FBS
and penicillin/streptomycin). Hopefully, this would prevent apoptosis in the endothelial
cells. During the analyzation of results, it would also be beneficial to look at the gene
expression in the cellular interactions.

In order to further understand the specific

mechanism behind these interactions we could inhibit specific cytokines and growth
factors on one cell type and co-culture the cells again to see if there are still biomarkers
of calcification. If there are not when a certain cytokine is blocked, that means that
cytokine is responsible in the interaction between the cells in diabetic conditions.
A 3D cell culture should also be performed with spheroids in order to analyze any
differences that the cultures have from the 2D cultures. After the spheroid study, it would
be necessary to seed all three cell types onto a decellularized scaffold in order to analyze
their interactions with each other and the ECM components and fluid flow. The
importance of fluid flow on the vascular cells is highlighted in the introduction, but this
study did not include that data. It is not a complete vascular calcification model without
the ECM components and fluid dynamics.
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